Table of Content

1. Drug Overview
1.1. Product Detail
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4. Research and development activity
1.4.1. Clinical Development
1.4.2. Safety and Efficacy
1.5. Other Development Activities

2. Market Assesment
2.1. 7MM Market Analysis
2.2. The United States Market
2.3. Germany Market
2.4. France Market
2.5. Italy Market
2.6. Spain Market
2.7. United Kingdom Market
2.8. Japan Market

3. SWOT Analysis

4. Analyst Views

5. Market Competitors

6. Other Emerging Therapies

7. Appendix

8. Report Purchase Options



List of Figures


Figure 1 The Development Timeline of OTILIMAB (GSK3196165)
Figure 2 Patent Details, OTILIMAB (GSK3196165)
Figure 3 OTILIMAB (GSK3196165), 7MM Market Size from 2020 to 2030 (in Million USD)
Figure 4 OTILIMAB (GSK3196165), US Market Size from 2020 to 2030 (in Millions USD)
Figure 5 OTILIMAB (GSK3196165), EU5 Market Size from 2020 to 2030 (in Millions USD)
Figure 6 OTILIMAB (GSK3196165), Japan Market Size from 2020 to 2030 (in Millions USD)


List of Tables


Table 1 OTILIMAB (GSK3196165), Description
Table 2 OTILIMAB (GSK3196165), Clinical Trial Description
Table 3 OTILIMAB (GSK3196165), 7MM Market Size from 2020 to 2030 (in Million USD)
Table 4 Market Competitors
Table 5 Other Emerging Therapies